CID 15602270

15a,26,27-trihydroxy-7a-methoxy-8,24-lanostadien-3-one

Structural Information

Molecular Formula
C31H50O5
SMILES
CC(CCC=C(CO)CO)C1CC(C2(C1(CCC3=C2C(CC4C3(CCC(=O)C4(C)C)C)OC)C)C)O
InChI
InChI=1S/C31H50O5/c1-19(9-8-10-20(17-32)18-33)22-15-26(35)31(6)27-21(11-14-30(22,31)5)29(4)13-12-25(34)28(2,3)24(29)16-23(27)36-7/h10,19,22-24,26,32-33,35H,8-9,11-18H2,1-7H3
InChIKey
SQJBJGSQYVYNPM-UHFFFAOYSA-N
Compound name
15-hydroxy-17-[7-hydroxy-6-(hydroxymethyl)hept-5-en-2-yl]-7-methoxy-4,4,10,13,14-pentamethyl-1,2,5,6,7,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

502.3658 Da
Monoisotopic Mass

4.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 503.37308 222.4
[M+Na]+ 525.35502 226.9
[M+NH4]+ 520.39962 232.8
[M+K]+ 541.32896 216.2
[M-H]- 501.35852 221.3
[M+Na-2H]- 523.34047 222.2
[M]+ 502.36525 222.9
[M]- 502.36635 222.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.